This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE! After-Hours Headlines

Stocks in this article: CRM FB ARO MRVL SQNM

NEW YORK ( TheStreet) -- Here's the rundown on companies making news after Thursday's closing bell.

Shares of (CRM) jumped 7.2% to $143.49 on volume of nearly 800,000, according to, after the cloud and software technology company reported non-GAAP earnings of $54.5 million, or 37 cents a share, on revenue of $695.5 million for its fiscal first quarter.

The average estimate of analysts polled by Thomson Reuters was for a profit of 34 cents a share on revenue of $678.2 million in the April-ended period. also forecast non-GAAP earnings of 38 to 39 cents a share for the second quarter ending in July vs. Wall Street's consensus view for a profit of 38 cents a share.

Marvell Technology

Marvell Technology (MRVL) was a winner in Thursday's extended session after the Santa Clara, Calif.-based chip maker reported better than expected quarterly results, initiated a dividend and boosted its buyback program.

The company reported non-GAAP earnings of $139 million, or 23 cents a share, for the first quarter on revenue of $796.4 million, besting the average analysts' view of for a profit of 20 cents a share on revenue of $768.7 million.

Marvell also said its board has approved a quarterly dividend of 6 cents a share and increased its repurchase authorization by $500 million to $2.5 billion. The stock was last quoted at $13.80, up 3.8%. on volume of more than 500,000.


Shares of Sequenom (SQNM) were down in late trades after the company said Coventry Health Care (CVH) has opted to terminate a coverage agreement between the two companies.

Sequenom said Coventry had opted to terminate the agreement without cause effective August 31, and that it advised that "this decision was not a judgment" on Sequenom or its products. The deal would have provided coverage for Sequenom's MaterniT21 PLUS laboratory-developed test and other similar products within Coventry's network.

The stock was last quoted at $4.40, off 7.8%, on volume of nearly 90,000, according to

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 18,030.21 +6.04 0.03%
S&P 500 2,081.88 -0.29 -0.01%
NASDAQ 4,773.4720 +8.0480 0.17%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs